Clinical Trial Update: Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial comparing standard-dose versus double-dose amoxicillin for WHO-defined non-severe pneumonia. It is a Phase 1/2 study that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: ARI Research Cell | Conditions: Pneumonia | Phase 1, Phase 2 | Status: COMPLETED